1 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow Pablo Ingelmo: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of the Efficacy of the Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Daily Headache in Children and Adolescents. Sphenopalatine ganglion block with 0.5% bupivacaine, Sphenopalatine ganglion block with saline - Chronic Daily Headache, Post-Traumatic Headache | Not applicable | Unknown | Pablo Ingelmo | 120 | 2022-02-05 | 2022-01-28 |
Headache Disorders (1) · Post-Traumatic Headache (1)
Bupivacaine (1) · Sodium Chloride (1) · Sphenopalatine Ganglion Block (1)
Canada (1)